Fresenius Medical Care AG & Co. KGaA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fresenius Medical Care AG & Co. KGaA generated cash of $2,628,801,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,858,529,000 last year. Net change in cash is therefore $153,438,000.
Cash Flow
| 2014 | 1.53B | -2.21B | 662.00M |
|---|---|---|---|
| 2015 | 1.79B | -915.28M | -921.55M |
| 2016 | 2.03B | -1.31B | -556.01M |
| 2017 | 2.19B | -991.54M | -798.63M |
| 2018 | 2.06B | -245.03M | -681.73M |
| 2019 | 2.56B | -3.28B | -466.63M |
| 2020 | 4.23B | -1.33B | -2.66B |
| 2021 | 2.48B | -1.19B | -1.02B |
| 2022 | 2.16B | -734.72M | -1.61B |
| 2023 | 2.62B | -544.22M | -1.85B |
FMS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.27B | 1.48B | 1.08B | 1.00B | 2.14B | 978.10M | 708.88M | 522.48M | 579.76M | 561.48M |
Operating activities | ||||||||||
Net income | 732.45M | 895M | 1.21B | 1.43B | 1.43B | 2.22B | 1.55B | 1.47B | 1.20B | 1.03B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.75B | 1.83B | 1.62B | 1.78B | 1.59B | 725M | 736M | 736.90M | 655.81M | 574.82M |
Stock-based compensation expense | 32.51M | -5.87M | 28.29M | 40.89M | 1.99M | 10.74M | 46.81M | 28.69M | 11.27M | 6.99M |
| Deferred income tax benefit | 32.51M | -5.87M | 28.29M | 40.89M | 1.99M | 10.74M | 46.81M | 28.69M | 11.27M | 6.99M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -151.84M | -46.68M | -163.19M | 71.69M | -64.11M | -170.49M | -86.24M | -305.91M | -302.99M | -227.14M |
Inventories | -13.14M | -204.30M | -48.53M | -355.83M | -117.50M | -157.09M | -62.69M | -63.39M | -275.32M | -70.52M |
Accounts payable | 108.47M | -356.78M | -363.95M | 1.37B | -164.76M | 368.39M | 518.74M | 170.56M | 526.99M | 193.45M |
Cash generated by operating activities | 2.62B | 2.16B | 2.48B | 4.23B | 2.56B | 2.06B | 2.19B | 2.03B | 1.79B | 1.53B |
Investing activities | ||||||||||
Purchases Of Investments | -102.36M | -106M | -129M | -96M | -2.17B | -925M | -151M | -348.95M | -60.36M | -1.45B |
Investments In Property Plant And Equipment | -684.59M | -1.41B | -1.68B | -2.08B | -2.23B | -2.06B | -1.78B | -1.94B | -1.72B | -1.52B |
Acquisitions Net | 136.99M | 1.02M | -381.72M | -244.37M | -2.17B | 757.70M | -150.30M | -348.95M | -59.59M | -1.45B |
Cash generated by investing activities | -544.22M | -734.72M | -1.19B | -1.33B | -3.28B | -245.03M | -991.54M | -1.31B | -915.28M | -2.21B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 20.15M | 6.51M | 2.92B | 0 | 1.52B | 0 | 47.46M | 84.91M | 0 |
Payments for dividends | -328.62M | -395.55M | -392.45M | -351.17M | -354.63M | -324.83M | -293.97M | -263.55M | -240.77M | -261.43M |
Repurchases of common stock | 0 | -20.15M | -6.51M | -365.98M | -599.79M | -37.22M | -57.93M | 0 | 0 | 0 |
Repayments of term debt | -1.25B | -1.02B | -3.40B | -4.18B | 318.54M | -1.31B | -308.33M | -1.20B | -549.40M | -1.79B |
Cash used in financing activities | -1.85B | -1.61B | -1.02B | -2.66B | -466.63M | -681.73M | -798.63M | -556.01M | -921.55M | 662.00M |
Net Change In Cash | 153.43M | -207.86M | 400.11M | 73.81M | -1.13B | 1.16B | 269.22M | 188.01M | -77.15M | -40.23M |
Cash at end of period | 1.42B | 1.27B | 1.48B | 1.08B | 1.00B | 2.14B | 978.10M | 710.49M | 502.60M | 521.25M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |